Metabolic dysfunction-associated fatty liver disease and hepatocellular carcinoma: present and future

被引：8
|
作者：
Gao, Feng [1 ]
Chen, Gang [2 ,3 ,4 ]
Byrne, Christopher D. [5 ,6 ]
Targher, Giovanni [7 ,8 ]
Cheung, Tan To [9 ]
Zheng, Ming-Hua [10 ,11 ,12 ,13 ]
机构：
[1] Wenzhou Med Univ, Dept Anesthesiol, Affiliated Hosp 1, Wenzhou, Peoples R China
[2] Wenzhou Med Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Wenzhou, Peoples R China
[3] Wenzhou Med Univ, Key Lab Diag & Treatment Severe Hepatopancreat Dis, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China
[4] Wenzhou Med Univ, Hepatobiliary Pancreat Tumor Bioengn Cross Int Joi, Affiliated Hosp 1, Wenzhou, Peoples R China
[5] Univ Hosp Southampton, Southampton Natl Inst Hlth & Care Res, Biomed Res Ctr, Southampton, England
[6] Univ Southampton, Southampton Gen Hosp, Southampton, England
[7] Univ Verona, Dept Med, Verona, Italy
[8] IRCCS Sacro Cuore Don Calabria Hosp, I-37024 Negrar Di Valpolicella, Italy
[9] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Peoples R China
[10] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, NAFLD Res Ctr, Wenzhou, Peoples R China
[11] Wenzhou Med Univ, Inst Hepatol, Wenzhou, Peoples R China
[12] Key Lab Diag & Treatment Dev Chron Liver Dis Zheji, Wenzhou, Peoples R China
[13] Wenzhou Med Univ, Affiliated Hosp 1, Dept Hepatol, MAFLD Res Ctr, 2 Fuxue Lane, Wenzhou 325000, Peoples R China
来源：
HEPATOBILIARY SURGERY AND NUTRITION | 2023年 / 12卷 / 06期
基金：
中国国家自然科学基金;
关键词：
Metabolic dysfunction-associated fatty liver disease (MAFLD); metabolic dysfunction-associated steatotic liver disease; nonalcoholic fatty liver disease; hepatocellular carcinoma (HCC); epidemiology;
D O I：
10.21037/hbsn-23-539
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：945 / 948
页数：4
相关论文
共 50 条
  • [1] Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma
    Song, Byeong Geun
    Choi, Sung Chul
    Goh, Myung Ji
    Kang, Wonseok
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Paik, Seung Woon
    JHEP REPORTS, 2023, 5 (09)
  • [2] Hepatocellular Carcinoma in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Rodriguez, Luis A.
    Schmittdiel, Julie A.
    Liu, Liyan
    Macdonald, Brock A.
    Balasubramanian, Sreepriya
    Chai, Krisna P.
    Seo, Suk I.
    Mukhtar, Nizar
    Levin, Theodore R.
    Saxena, Varun
    JAMA NETWORK OPEN, 2024, 7 (07) : e2421019
  • [3] Incidence of Cirrhosis and Hepatocellular Carcinoma Among Veterans With Noncirrhotic Metabolic Dysfunction-associated Fatty Liver Disease
    Yeoh, Aaron
    Yang, Zeyuan
    Cheung, Ramsey
    Do, Albert
    Ahmed, Aijaz
    Wong, Robert J.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2024, 58 (07) : 718 - 725
  • [4] Impact of metabolic dysfunction-associated fatty liver disease on the outcomes following laparoscopic hepatectomy for hepatocellular carcinoma
    Xu, Hongwei
    Liu, Yani
    Wei, Yonggang
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2024, 38 (11): : 6456 - 6463
  • [5] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
  • [6] Phenotypes of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatocellular Carcinoma
    Esteban, Jesus Rivera-
    Munoz-Martinez, Sergio
    Higuera, Monica
    Sena, Elena
    Bermudez-Ramos, Maria
    Banares, Juan
    Martinez-Gomez, Maria
    Cusido, M. Serra
    Jimenez-Masip, Alba
    Francque, Sven M.
    Tacke, Frank
    Minguez, Beatriz
    Pericas, Juan M.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (09)
  • [7] Diabetes and metabolic dysfunction-associated fatty liver disease
    Davis, Timothy M. E.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 123
  • [8] Metabolic dysfunction associated fatty liver disease and the risk of hepatocellular carcinoma
    Song, Byeong Geun
    Kim, Aryoung
    Choi, Sung Chul
    Goh, Myungji
    Kang, Wonseok
    Gwak, Geum-Yon
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Paik, Seung Woon
    Sinn, Dong Hyun
    JOURNAL OF HEPATOLOGY, 2023, 78 : S631 - S631
  • [9] Metabolic dysfunction-associated fatty liver disease related hepatocellular carcinoma in China: An increasing problem: Letter to the edioron "Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis"
    Wu, Xiangyu
    Ni, Wenjing
    Chen, Qianqian
    Shi, Junping
    Li, Jie
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (04)
  • [10] The impact of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with hepatocellular carcinoma after radical resection
    Xiong, Ke-Gong
    Ke, Kun-Yu
    Chen, Li-Fang
    Kong, Jin-Feng
    Lin, Tai-Shun
    Lin, Qing-Biao
    Lin, Su
    Zhu, Yue-Yong
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2023, 22 (04) : 366 - 372
12345